MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, SPRB had -$28,084K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$28,084K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-24,320 -
Stock-based compensation expense
882 -
Depreciation and amortization
16 -
Non-cash lease expense
199 -
Loss on disposal of property and equipment
0 -
Change in fair value of warrant liability
-517 -
Prepaid expenses and other current assets
-1,606 -
Other assets
0 -
Accounts payable
91 -
Accrued expenses and other current liabilities
-4,310 -
Deferred revenue
0 -
Other liabilities
-518 -
Net cash used in operating activities
-26,871 -
Proceeds from exercise of common stock options
0 -
Proceeds from issuance of common stock related to employee stock purchase plan
3 -
Repayment of term loan
1,216 -
Tax withholding payments on restricted stock units
0 -
Net cash used in financing activities
-1,213 -
Restricted cash
-35
Net decrease in cash, cash equivalents, and restricted cash
-28,084 -
Cash and cash equivalents, at carrying value, ending balance
-16,387
Cash and cash equivalents at beginning of period
38,788 -
Cash and cash equivalents at end of period
10,704 16,422
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

SPRUCE BIOSCIENCES, INC. (SPRB)

SPRUCE BIOSCIENCES, INC. (SPRB)